Related Experiment Video
Updated: May 19, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial fibrillation ablation and heart failure
Jonathan Man1, Francis E Marchlinski
1Department of Medicine, Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, 9 Founders Pavilion-Cardiology, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Current Cardiology Reports
|August 14, 2012
Summary
Atrial fibrillation (AF) significantly worsens outcomes for patients with systolic heart failure (HF). Catheter ablation to restore sinus rhythm improves heart function and reduces HF symptoms, offering a superior approach to other treatments.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Atrial fibrillation (AF) is linked to worse outcomes in systolic heart failure (HF).
- HF increases the risk of developing AF by 5- to 6-fold.
- AF can exacerbate left ventricular (LV) systolic dysfunction through rapid rates, irregular rhythms, and mitral regurgitation.
Purpose of the Study:
- To evaluate the efficacy of catheter ablation for AF in patients with heart failure.
- To compare catheter ablation with other treatments like AV node ablation and biventricular pacing.
- To assess the impact of restoring sinus rhythm on LV function and HF symptoms.
Main Methods:
- Review of studies investigating catheter ablation for AF in heart failure patients.
- Comparison of outcomes (ejection fraction, HF symptoms) between ablation and other interventions.
- Analysis of the effect of sinus rhythm restoration on cardiac function.
Main Results:
- Catheter ablation for AF can improve ejection fraction in heart failure patients.
- Restoring sinus rhythm through ablation reduces heart failure symptoms.
- Catheter ablation appears superior to AV node ablation and biventricular pacing for AF in HF.
Conclusions:
- Catheter ablation is an effective strategy for managing atrial fibrillation in patients with systolic heart failure.
- Restoring sinus rhythm via ablation improves cardiac function and alleviates HF symptoms.
- Further research is needed to determine optimal patient selection for rhythm control and efficacy in diastolic heart failure.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...